help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gansler, T.
Right arrow Articles by Garvin, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gansler, T.
Right arrow Articles by Garvin, A. J.

American Journal of Pathology, Vol 130, 431-435, Copyright © 1988 by American Society for Investigative Pathology


REGULAR ARTICLES

Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors

T Gansler, KD Allen, CF Burant, T Inabnett, A Scott, MG Buse, DA Sens and AJ Garvin
Department of Pathology, Medical University of South Carolina, Charleston 29425.

Insulinlike growth factors (IGFs) are peptide hormones that regulate proliferation and differentiation of several types of normal and neoplastic cells. Recent studies of Wilms' tumor, a childhood kidney neoplasm, have detected increased expression of IGF-2 mRNA and protein. The present report describes detection of Type 1 IGF receptors in specimens of Wilms' tumor and adjacent nonneoplastic kidney tissue. These receptors recognize both IGF-1 and IGF-2, and binding of either peptide activates endogenous tyrosine kinase activity of the Type 1 IGF receptor beta subunit. These data indicate that Wilms' tumors contain receptors that recognize and respond to exogenous IGF in vitro, and that autocrine IGF production might contribute to the increased proliferation and abnormal differentiation of these cells in vivo.


This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Natrajan, J. S. Reis-Filho, S. E. Little, B. Messahel, M.-A. Brundler, J. S. Dome, P. E. Grundy, G. M. Vujanic, K. Pritchard-Jones, and C. Jones
Blastemal Expression of Type I Insulin-Like Growth Factor Receptor in Wilms' Tumors Is Driven by Increased Copy Number and Correlates with Relapse
Cancer Res., December 1, 2006; 66(23): 11148 - 11155.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J Trojan, T. Johnson, S. Rudin, J Ilan, M. Tykocinski, and J Ilan
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA
Science, January 1, 1993; 259(5091): 94 - 97.
[Abstract] [PDF]


Home page
ScienceHome page
I. Drummond, S. Madden, P Rohwer-Nutter, G. Bell, V. Sukhatme, and F. Rauscher 3rd
Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1
Science, July 31, 1992; 257(5070): 674 - 678.
[Abstract] [PDF]


Home page
ScienceHome page
T Glaser, J Lane, and D Housman
A mouse model of the aniridia-Wilms tumor deletion syndrome
Science, November 9, 1990; 250(4982): 823 - 827.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.